Population pharmacokinetic and exposure-response analysis for trastuzumab administered using a subcutaneous "manual syringe" injection or intravenously in women with HER2-positive early breast cancer.
第一作者:
Angelica L,Quartino
第一单位:
Genentech, Inc., California, CA, USA.
作者:
主题词
抗肿瘤药(Antineoplastic Agents);生物利用度(Biological Availability);乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);人类(Humans);输注, 静脉内(Infusions, Intravenous);注射, 皮下(Injections, Subcutaneous);Logistic模型(Logistic Models);非线性动力学(Nonlinear Dynamics);注射器(Syringes);组织分布(Tissue Distribution)
DOI
10.1007/s00280-015-2922-5
PMID
26645407
发布时间
2018-11-13
- 浏览3
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文